Nabriva Therapeutics plc Restructuring Costs
Nabriva Therapeutics plc reported Restructuring Costs of $5.40 million for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-10-19.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:RestructuringCosts · last filed 2023-10-19
- Nabriva Therapeutics plc restructuring costs for the quarter ending 2023-06-30 was $5.40M.
- Nabriva Therapeutics plc restructuring costs for the quarter ending 2023-03-31 was $3.80M.
| Period end | Restructuring Costs 1 month | Restructuring Costs 3 month | Restructuring Costs 6 month |
|---|---|---|---|
| 2023-06-30 | $5.40M 10-Q · filed 2023-10-19 | $5.40M 10-Q · filed 2023-10-19 | |
| 2023-03-31 | $3.80M 10-Q · filed 2023-05-22 | ||
| 2023-01-31 | $5.40M 10-Q · filed 2023-05-22 |